ACTIVE_LEGS: Impact of Physical Activity as a Coadjuvant Treatment in the Healing of Venous Ulcers in Primary Health Care.

Sponsor
Gerencia de Atención Primaria, Madrid (Other)
Overall Status
Recruiting
CT.gov ID
NCT04039789
Collaborator
(none)
224
1
2
31.5
7.1

Study Details

Study Description

Brief Summary

Objectives: To evaluate the effectiveness of a structured educational intervention in physical exercise "Active Legs" as an adjuvant treatment to improve the healing of chronic venous ulcers at 3 months of follow-up, compared with the usual practice in people treated in primary care. Secondary objectives: To evaluate if the intervention active legs as an adjuvant treatment produces better results than usual practice in: degree of healing, recurrence, complete healing at 6 months, pain and quality of life. Describe degree of adherence and satisfaction with the intervention. Design: Randomized, multicenter, pragmatic, open clinical trial of parallel groups with 6 months of follow-up. Setting: Primary Care Health Centers (Madrid). Subjects: Patients with venous ulcers, with treatment in the nursing consultation of the participating centers. Sample: 224 participants (112 in each group). Intervention: Both groups will receive the usual treatment of cleaning, debridement based on humid environment cure and multilayer compression therapy according to the recommendations of Community of Madrid. The intervention group will also receive the structured educational intervention of lower limbs physical exercise and daily walking patterns. Variables: Main: complete healing at 3 months follow-up. Secondary: Degree of healing; ulcer area; quality of life; pain, related to the healing process, prognosis and recurrences; Sociodemographic and related adherence and satisfaction. Data analysis: Main effectiveness: comparison of the incidence of ulcers with complete healing at 3 months of follow-up in both groups, time to complete healing (Kaplan-Meier and Log-rank test). Adjustment of prognostic factors (Cox regression).

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Project active legs
  • Procedure: Usual care
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
224 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Randomised, multicentre clinical trial, parallel, pragmatic, with 6 months of follow-up.Randomised, multicentre clinical trial, parallel, pragmatic, with 6 months of follow-up.
Masking:
None (Open Label)
Masking Description:
Intervention can't be masked. We will objectify primary outcome by photography images and adherence to exercise through the use of pedometers. Statistician conducting the analysis will not know to which study arm a given patient has been assigned.
Primary Purpose:
Treatment
Official Title:
Impact of Physical Activity as a Coadjuvant Treatment in the Healing of Venous Ulcers in Primary Health Care: Multicenter Randomized Clinical Trial - Active Legs Project
Actual Study Start Date :
May 17, 2021
Anticipated Primary Completion Date :
Jun 30, 2022
Anticipated Study Completion Date :
Dec 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Control

Usual Care: that consists of healing the wound (assessment, cleaning, disinfection, debridement and topical treatment) and compression therapy multilayer usual practice, according to the recommendations for the treatment of cutaneous ulcers of the Region of Madrid.

Procedure: Usual care
Evaluation, cleaning, debridement, topical treatment (moist healing) and compressive therapy according to the recommendations for the treatment of chronic cutaneous ulcers of the Community of Madrid.

Experimental: Intervention

ACTIVE LEGS: The usual care plus experimental intervention. It is a structured educational intervention, directed by nurses and carried out in the health center consultations. The intervention "Active Legs" has been designed based on the available evidence. It incorporates a program of lower limb exercise at home and daily walking patterns. Home program of lower limb exercises. The nurse will instruct the patients in the performance of 4 exercises of lower limbs of progressive difficulty that must be performed at home 5 days a week, twice a day Daily walking program. In addition, patients must ambulate progressively until reaching the marked goal (150 min / week (30 minutes for 5 days a week)) . At the start of the study, the "Active Legs" diary will be provided, showing the patterns of the exercise and walking program graphically and a pedometer.

Behavioral: Project active legs
Home program of exercises of lower extremities includes the performance of 4 exercises of lower extremities of progressive difficulty that must be carried out at home 5 days a week, twice a day and walking progressively until reaching the marked goal (150 min / week (30 minutes for 5 days a week)).

Procedure: Usual care
Evaluation, cleaning, debridement, topical treatment (moist healing) and compressive therapy according to the recommendations for the treatment of chronic cutaneous ulcers of the Community of Madrid.

Outcome Measures

Primary Outcome Measures

  1. Complete healing at 6 months of follow-up [6 months]

    (yes/no) (complete and sustained epithelialisation for at least 2 weeks).

  2. Time elapsed between start of the study and complete healing of the wound [6 months]

    (in days)

Secondary Outcome Measures

  1. Degree of healing (Resvech 2.0) [Measured at the beginning (basal) and fortnightly up to 3 months and at 6 months.]

    The questionnaire consists of 6 dimensions with ascending scoring scales according to the severity of the dimension studied. It is divided into: depth (0 to 4), size (0 to 6), borders (0 to 4), wound bed (0 to 4), exudate (0 to 3) and signs and symptoms of infection (0 to 14). The total score ranges from 0 to 35.

  2. Ulceral area [Measured at the beginning (basal) and fortnightly up to 3 months and at 6 months.]

    In cm2. Measured by digital photography. Measurement through digital photography and subsequent treatment of the image using the open source Java image processing program "The ImageJ ecosystem" and its subsequent calculation using the Visitrack device.

  3. Health-related quality of life for patients with venous ulcers (CCVUQ-e) [Measured at the beginning (baseline), in the middle (3 months) and at the end of the study (6 months).]

    It is a questionnaire that measures quality of life in patients with venous ulcers. In addition to a global synthetic quality of life score, it has 4 dimensions: Social interaction, Cosmesis (body image), Emotional state and Domestic activities. Both the general score and the dimensions have a score that ranges from 0 to 100, where 0 is the best quality of life and 100 the worst quality of life.

  4. Perceived pain: visual analogical scale of the McGill questionnaire [Measured at the beginning (baseline), in the middle (3 months) and at the end of the study (6 months).]

    The visual analogical scale of the McGill questionnaire will be used. A greater than 20mm in the Visual Analog Scale of pain scale will be considered a clinically significant change. It goes from "no pain" 0 to "unbearable pain" 10, the patient will mark that point on the line that best reflects the pain he suffers.

  5. Level of adherence to the intervention "Active Legs". Number of steps. [In the intervention group. Measured biweekly coinciding with follow-up visits up to 3 months and 6 months.]

    Daily record using the Yamax PZ270 pedometer (15 days memory)

  6. Level of adherence to the intervention "Active Legs". Time. [In the intervention group. Measured biweekly coinciding with follow-up visits up to 3 months and 6 months.]

    The time in minutes / day

  7. Level of adherence to the intervention "Active Legs". The self-reported information by the patient of the domiciliary exercise program. [In the intervention group. Measured biweekly coinciding with follow-up visits up to 3 months and 6 months.]

    By registering in the activity diary, classifying it as "Excellent" in 75% or more of the prescribed sessions, "Good" between 50-74%, "Moderate" between 25-49% and "Poor" less than 25%.

  8. Age (sociodemographic variables) [Measured at the beginning (baseline)]

    in years

  9. Sex (sociodemographic variables) [Measured at the beginning (baseline)]

    Male/Female

  10. Living alone (sociodemographic variables) [Measured at the beginning (baseline)]

    Yes/no

  11. Employment status (sociodemographic variables) [Measured at the beginning (baseline)]

    housewife / unemployed / student / worker employee account / worker own account

  12. Education level (sociodemographic variables) [Measured at the beginning (baseline)]

    low / medium / high

  13. Weight (variables related to the healing process) [Measured at the beginning (baseline)]

    in kilograms. weight and height will be combined to report BMI in kg/m^2

  14. Height (variables related to the healing process) [Measured at the beginning (baseline)]

    in meters. weight and height will be combined to report BMI in kg/m^2

  15. Underlying disease (variables related to the healing process) [Measured at the beginning (baseline)]

    (yes / no) for heart failure, renal failure, hypertension, diabetes mellitus, rheumatoid arthritis, asthma, chronic obstructive pulmonary disease, osteoarthritis, deep vein thrombosis, peripheral arterial vasculopathy, varicose veins.

  16. ABI (variables related to the healing process) [Measured at the beginning (baseline)]

    The Ankle Brachial Index (ABI) is the systolic pressure at the ankle, divided by the systolic pressure at the arm. It has been shown to be a specific and sensitive metric for the diagnosis of Peripheral Arterial Disease (PAD).

  17. Tobacco consumption (variables related to the healing process) [Measured at the beginning (baseline)]

    no smoker / smoker / ex-smoker

  18. Alcohol consumption (variables related to the healing process) [Measured at the beginning (baseline)]

    volume grams of alcohol / week

  19. Topical and systemic treatment (variables related to the healing process) [Measured at the beginning (baseline)]

    (yes/no) for hydrocellular dressings, alginates, hydrogels, collagenase, silver dressings, low adhesion dressings, silver sulfadiazine in ointment, other antibiotics in ointment, moisturizing products for the skin.

  20. Adherence to multilayer compression therapy (variables related to the healing process) [Measured at the beginning (basal) and fortnightly until 3 months and at 6 months .]

    (yes/no)

  21. Physical activity level measured by the Minnesota free time physical activity questionnaire (variables related to the healing process) [Measured at the beginning (baseline), in the middle (3 months) and at the end of the study (6 months).]

    It allows to measure the energy expenditure during free time and allows to classify individuals in activity categories. In metabolic energy turnover (METS)-min/14 days. Interpreting as: very active above 5000 METS-min / 14 days, Active between 3000 and 4999 METS-min / 14 days, Moderately active between 1250 and 2999 METS-min / 14 days and sedentary less than 1250 METS-min / 14 days .

  22. Type of daily walking (variables related to the healing process) [Measured at the beginning (baseline)]

    Independent / Independent with technical assistance (cane, crutches or walker with or without wheels) / With the help of the participation of a person without technical assistance / With the help of the participation of a person with technical help

  23. Location of the ulcer (prognostic variables) [Measured at the beginning (baseline)]

    internal lateral aspect/ supra-malleolar area/ anterior area of the leg/ external lateral aspect of the leg/ posterior aspect of the leg

  24. Number of ulcers at the time of the study (prognostic variables) [Measured at the beginning (baseline)]

    in number

  25. Time in days of evolution of the venous ulcers before inclusion in the study (prognostic variables) [Measured at the beginning (baseline)]

    in days

  26. Recurrent ulcer (prognostic variables) [Measured at the beginning (baseline)]

    (yes/no)

  27. Recurrence (variables related to recurrences) [measured at 6 months of follow-up]

    (yes / no)

  28. Use of compression stockings (variables related to recurrences) [measured at 6 months of follow-up]

    (Yes/no) for Light / normal / strong compression

  29. Hydration of the legs (variables related to recurrences) [measured at 6 months of follow-up]

    (Yes/no)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Individuals with a diagnosis of venous ulcers registered in electronic clinical history (history of chronic venous insufficiency and/or venous ulcer) and presence of an ankle brachial index (ABI) greater than 0.8 and less than 1.3.

  • Presence at least a venous ulcer of 1cm or more in diameter. If the participant has more than one lesion, the nurse will select the lesion with the highest Resvech 2.0 score for the study.

  • Independent ambulation or with the help of devices.

  • Individuals who able to follow the demands of the trial and who provide their written informed consent to participate.

Exclusion Criteria:
  • Patients with mixed ulcers.

  • Acute phase deep vein thrombosis.

  • Patients on treatment with antineoplastic agents.

  • Decompensated heart failure.

  • Rheumatoid arthritis.

  • Acute phase dermatitis, at the time of the study.

  • Patients immobilized at home, institutionalized or displaced residing outside the area where the research is conducted for more than 6 months a year or during the performance of the intervention.

  • Absolute contraindication to perform physical exercise.

  • Patients who are simultaneously participating in another clinical trial.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Borja Jesús Herraiz Ahijado Madrid Spain

Sponsors and Collaborators

  • Gerencia de Atención Primaria, Madrid

Investigators

  • Principal Investigator: Borja Jesús Herraiz Ahijado, Nurse, Gerencia Asistencial de Atención Primaria de la Comunidad de Madrid

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Borja Jesús Herraiz Ahijado, Principal Investigator. Clinical nurse, Gerencia de Atención Primaria, Madrid
ClinicalTrials.gov Identifier:
NCT04039789
Other Study ID Numbers:
  • CCI 11/18
First Posted:
Jul 31, 2019
Last Update Posted:
May 25, 2021
Last Verified:
May 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Borja Jesús Herraiz Ahijado, Principal Investigator. Clinical nurse, Gerencia de Atención Primaria, Madrid
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 25, 2021